Coronary artery bypass graft (CABG) carried a lower mortality risk in non-ST-elevation myocardial infarction (NSTEMI) patients undergoing revascularization for left main coronary artery disease (LM CAD) than percutaneous coronary intervention (PCI) in the latest analysis of a national online Swedish registry.